Modulation of chemosensitivity in human colon carcinoma cells by downregulating Protein Kinase Cα expression

Subhas Chakrabarty, Shuang Huang

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Protein kinase C (PKC) is thought to play a role in tumor progression and drug resistance of colon carcinomas. Specifically, the PKCα isoform has been implicated in drug resistance and responsiveness of colon carcinoma cells to growth factors. Therefore, in this study we determined the effect of downregulating PKCα expression by transfecting human colon carcinoma cells with an antisense PKCα expression vector and then determined the sensitivity of these cells to the anticancer drugs mitomycin C (MMC), 5-fluorouracil (5-FU) and vincristine (Vin). Transiently transfecting the human colon carcinoma cell lines Moser, SW480 and HT29 with antisense PKCα expression vector (but not antisense PKCβ expression vector) consistently increased the sensitivity of these cells to MMC, 5-FU and VIN by several-fold. Sensitivity to these drugs was then further determined in the Moser colon carcinoma cell line stably transfected with antisense PKCα expression vector. This stably transfected cell line, which expressed a high level of antisense PKCα RNA with a concurrent reduction of PKCα protein expression, was found to exhibit an increased sensitivity to these anticancer drugs. Thus, strategies designed to downregulate PKCα expression may have potential in improving the responses of colon carcinoma cells to cytotoxic drugs.

Original languageEnglish (US)
Pages (from-to)218-221
Number of pages4
JournalJournal of Experimental Therapeutics and Oncology
Volume1
Issue number4
StatePublished - Jul 1 1996

Fingerprint

Protein Kinase C
Colon
Down-Regulation
Carcinoma
Mitomycin
Drug Resistance
Cell Line
Fluorouracil
Pharmaceutical Preparations
Vincristine
Intercellular Signaling Peptides and Proteins
Protein Isoforms
RNA

Keywords

  • Chemosensitivity
  • Colon carcinomas
  • Protein Kinase C

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Cancer Research

Cite this

Modulation of chemosensitivity in human colon carcinoma cells by downregulating Protein Kinase Cα expression. / Chakrabarty, Subhas; Huang, Shuang.

In: Journal of Experimental Therapeutics and Oncology, Vol. 1, No. 4, 01.07.1996, p. 218-221.

Research output: Contribution to journalArticle

@article{0a17e602e11444a0a0e2ad6f0f30e16a,
title = "Modulation of chemosensitivity in human colon carcinoma cells by downregulating Protein Kinase Cα expression",
abstract = "Protein kinase C (PKC) is thought to play a role in tumor progression and drug resistance of colon carcinomas. Specifically, the PKCα isoform has been implicated in drug resistance and responsiveness of colon carcinoma cells to growth factors. Therefore, in this study we determined the effect of downregulating PKCα expression by transfecting human colon carcinoma cells with an antisense PKCα expression vector and then determined the sensitivity of these cells to the anticancer drugs mitomycin C (MMC), 5-fluorouracil (5-FU) and vincristine (Vin). Transiently transfecting the human colon carcinoma cell lines Moser, SW480 and HT29 with antisense PKCα expression vector (but not antisense PKCβ expression vector) consistently increased the sensitivity of these cells to MMC, 5-FU and VIN by several-fold. Sensitivity to these drugs was then further determined in the Moser colon carcinoma cell line stably transfected with antisense PKCα expression vector. This stably transfected cell line, which expressed a high level of antisense PKCα RNA with a concurrent reduction of PKCα protein expression, was found to exhibit an increased sensitivity to these anticancer drugs. Thus, strategies designed to downregulate PKCα expression may have potential in improving the responses of colon carcinoma cells to cytotoxic drugs.",
keywords = "Chemosensitivity, Colon carcinomas, Protein Kinase C",
author = "Subhas Chakrabarty and Shuang Huang",
year = "1996",
month = "7",
day = "1",
language = "English (US)",
volume = "1",
pages = "218--221",
journal = "Journal of Experimental Therapeutics and Oncology",
issn = "1359-4117",
publisher = "Old City Publishing",
number = "4",

}

TY - JOUR

T1 - Modulation of chemosensitivity in human colon carcinoma cells by downregulating Protein Kinase Cα expression

AU - Chakrabarty, Subhas

AU - Huang, Shuang

PY - 1996/7/1

Y1 - 1996/7/1

N2 - Protein kinase C (PKC) is thought to play a role in tumor progression and drug resistance of colon carcinomas. Specifically, the PKCα isoform has been implicated in drug resistance and responsiveness of colon carcinoma cells to growth factors. Therefore, in this study we determined the effect of downregulating PKCα expression by transfecting human colon carcinoma cells with an antisense PKCα expression vector and then determined the sensitivity of these cells to the anticancer drugs mitomycin C (MMC), 5-fluorouracil (5-FU) and vincristine (Vin). Transiently transfecting the human colon carcinoma cell lines Moser, SW480 and HT29 with antisense PKCα expression vector (but not antisense PKCβ expression vector) consistently increased the sensitivity of these cells to MMC, 5-FU and VIN by several-fold. Sensitivity to these drugs was then further determined in the Moser colon carcinoma cell line stably transfected with antisense PKCα expression vector. This stably transfected cell line, which expressed a high level of antisense PKCα RNA with a concurrent reduction of PKCα protein expression, was found to exhibit an increased sensitivity to these anticancer drugs. Thus, strategies designed to downregulate PKCα expression may have potential in improving the responses of colon carcinoma cells to cytotoxic drugs.

AB - Protein kinase C (PKC) is thought to play a role in tumor progression and drug resistance of colon carcinomas. Specifically, the PKCα isoform has been implicated in drug resistance and responsiveness of colon carcinoma cells to growth factors. Therefore, in this study we determined the effect of downregulating PKCα expression by transfecting human colon carcinoma cells with an antisense PKCα expression vector and then determined the sensitivity of these cells to the anticancer drugs mitomycin C (MMC), 5-fluorouracil (5-FU) and vincristine (Vin). Transiently transfecting the human colon carcinoma cell lines Moser, SW480 and HT29 with antisense PKCα expression vector (but not antisense PKCβ expression vector) consistently increased the sensitivity of these cells to MMC, 5-FU and VIN by several-fold. Sensitivity to these drugs was then further determined in the Moser colon carcinoma cell line stably transfected with antisense PKCα expression vector. This stably transfected cell line, which expressed a high level of antisense PKCα RNA with a concurrent reduction of PKCα protein expression, was found to exhibit an increased sensitivity to these anticancer drugs. Thus, strategies designed to downregulate PKCα expression may have potential in improving the responses of colon carcinoma cells to cytotoxic drugs.

KW - Chemosensitivity

KW - Colon carcinomas

KW - Protein Kinase C

UR - http://www.scopus.com/inward/record.url?scp=0030177190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030177190&partnerID=8YFLogxK

M3 - Article

C2 - 9414406

AN - SCOPUS:0030177190

VL - 1

SP - 218

EP - 221

JO - Journal of Experimental Therapeutics and Oncology

JF - Journal of Experimental Therapeutics and Oncology

SN - 1359-4117

IS - 4

ER -